logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

RevOpsis Therapeutics secured $16.5 million in seed funding to develop and commercialize treatments for neovascular AMD

Apr 25, 2024•over 1 year ago

Amount Raised

$16.5 Million

Round Type

seed

SpringfieldBiotechnology

Investors

Several Leading Retina SpecialistsVarious Private And Angel InvestorsOphthalmic Drug And Device Development FirmLeading Contract Development And Manufacturing Organization (Cdmo)

Description

RevOpsis Therapeutics has successfully closed its first seed funding round, raising $16.5 million. The funding will propel its mission to develop and commercialize treatments for chronic multifactorial diseases through the company's proprietary Rev-Mod Platform.

Company Information

Company

RevOpsis Therapeutics

Location

Springfield, Illinois, United States

About

RevOpsis Therapeutics is a next-generation biopharmaceutical company that is trailblazing a new era in multispecific antibody discovery and development to unlock transformative treatments for complex disease.

Related People

3 contacts

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech